Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how? (Q47357418)

http://europepmc.org/abstract/MED/29181713

14 January 2018

4 references

29 May 2020

2 November 2020

19 November 2020

3 July 2021

Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6311200&resulttype=core&format=json

13 May 2020

3 references

29 May 2020

2 November 2020

19 November 2020

1 reference

2 November 2020

1 reference

19 November 2020

1 reference

3 July 2021

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6311200&resulttype=core&format=json

13 May 2020

author name string

Rebecca Preston

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6311200&resulttype=core&format=json

13 May 2020

Helen M Stuart

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6311200&resulttype=core&format=json

13 May 2020

publication date

27 November 2017

1 reference

http://europepmc.org/abstract/MED/29181713

14 January 2018

1 February 2019

4 references

29 May 2020

2 November 2020

19 November 2020

3 July 2021

5 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6311200&resulttype=core&format=json

13 May 2020

29 May 2020

2 November 2020

19 November 2020

3 July 2021

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6311200&resulttype=core&format=json

13 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6311200&resulttype=core&format=json

13 May 2020

page(s)

195-210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6311200&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 May 2020

copyright license

4 references

29 May 2020

2 November 2020

19 November 2020

https://scigraph.springernature.com/pub.10.1007/s00467-017-3838-6

3 July 2021

0 references

0 references

cites work

Is there really an increase in non-minimal change nephrotic syndrome in children?

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Contributions of the Transplant Registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

21 January 2018

Genetic kidney diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Defects of CRB2 cause steroid-resistant nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

FAT1 mutations cause a glomerulotubular nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Donor splice-site mutations in WT1 are responsible for Frasier syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Biallelic Mutations in Nuclear Pore Complex Subunit NUP107 Cause Early-Childhood-Onset Steroid-Resistant Nephrotic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Pathogenesis of focal segmental glomerular sclerosis in a girl with the partial deletion of chromosome 6p.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Unique X-linked familial FSGS with co-segregating heart block disorder is associated with a mutation in the NXF5 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

NPHS2 homozygous p.R229Q variant: potential modifier instead of causal effect in focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Loss-of-function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

MYO1E mutations and childhood familial focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

MAGI2 Mutations Cause Congenital Nephrotic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

KANK deficiency leads to podocyte dysfunction and nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Functional analysis of promoter mutations in the ACTN4 and SYNPO genes in focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Disruption of PTPRO causes childhood-onset nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Mutations in EMP2 cause childhood-onset nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Exome sequencing reveals cubilin mutation as a single-gene cause of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Exome sequencing and in vitro studies identified podocalyxin as a candidate gene for focal and segmental glomerulosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Integrin α3 mutations with kidney, lung, and skin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Common variation in GPC5 is associated with acquired nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Modification defect at anticodon wobble nucleotide of mitochondrial tRNAs(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Focal segmental glomerulosclerosis in patients with mandibuloacral dysplasia owing to ZMPSTE24 deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Congenital disorder of glycosylation type Ik (CDG-Ik): a defect of mannosyltransferase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

A homozygous missense mutation in the ciliary gene TTC21B causes familial FSGS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Secondary focal and segmental glomerulosclerosis associated with single-nucleotide polymorphisms in the genes encoding complement factor H and C3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Nephrin mutations can cause childhood-onset steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Genetic screening in adolescents with steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

A novel TRPC6 mutation that causes childhood FSGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Mutational and Biological Analysis of alpha-actinin-4 in focal segmental glomerulosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Mutations in the human laminin beta2 (LAMB2) gene and the associated phenotypic spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

LMX1B mutations cause hereditary FSGS without extrarenal involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Circulating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed Candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

GINA, genetic discrimination, and genomic medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Genetics in public health: Rarely explored

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Who Pays? Coverage Challenges for Cardiovascular Genetic Testing in U.S. Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Participants and Study Decliners' Perspectives About the Risks of Participating in a Clinical Trial of Whole Genome Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Genetic testing in steroid-resistant nephrotic syndrome: when and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Genetics of hereditary nephrotic syndrome: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Genotype–phenotype associations in WT1 glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

A Case of Familial Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-017-3838-6

Congenital nephrotic syndrome: a novel phenotype of type I carbohydrate-deficient glycoprotein syndrome

21 January 2018

1 reference

12 December 2020

Spectrum of disease in familial focal and segmental glomerulosclerosis

1 reference

12 December 2020

Congenital focal segmental glomerulosclerosis associated with beta4 integrin mutation and epidermolysis bullosa

1 reference

12 December 2020

Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome

1 reference

12 December 2020

Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study

1 reference

12 December 2020

Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation

1 reference

12 December 2020

Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency

1 reference

12 December 2020

Genetic forms of nephrotic syndrome: a single-center experience in Brussels

1 reference

12 December 2020

Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis

1 reference

12 December 2020

Focal segmental glomerulosclerosis in a boy with Dent-2 disease

1 reference

12 December 2020

Genetics in clinical practice: nephrotic and proteinuric syndromes

1 reference

12 December 2020

Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA

1 reference

12 December 2020

10.1007/S00467-017-3838-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6311200&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6311200&resulttype=core&format=json

13 May 2020

1 reference